IN8bio, Inc. Share Price
NASDAQ: INAB | Micro CapIN8bio, Inc. Stock Performance
IN8bio, Inc. Share Price Chart
IN8bio, Inc. Quarterly Profit & Loss
All figures in USD
IN8bio, Inc. Annual Profit & Loss
All figures in USD
About IN8bio, Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
IN8bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.45 | $1.43 | +11.28% |
Sep 2026 | $1.11 | $1.28 | +31.12% |
Aug 2026 | $0.95 | $0.98 | -15.52% |
Jul 2026 | $1.43 | $1.16 | -18.60% |
Jun 2026 | $1.80 | $1.43 | -23.80% |
May 2026 | $1.50 | $1.87 | +26.35% |
Apr 2026 | $1.40 | $1.48 | +1.37% |
Mar 2026 | $1.73 | $1.46 | -14.37% |
Feb 2026 | $1.94 | $1.71 | -13.45% |
Jan 2026 | $2.32 | $1.97 | -15.81% |
Dec 2025 | $2.06 | $2.34 | +16.48% |
Nov 2025 | $1.86 | $2.01 | +4.09% |
INAB Share Price FAQs
What is IN8bio, Inc. share price today?
What is the 52 week high and 52 week low of IN8bio, Inc. stock?
What is INAB's market capitalisation today?
What is INAB's net income for the last quarter?
What is the 5 year returns of INAB?
What is the high & low stock price of INAB today?
Can I buy INAB shares in India?